These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 10398401

  • 1. Fine mapping of the antigen-antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster.
    Liu Z, Song D, Kramer A, Martin AC, Dandekar T, Schneider-Mergener J, Bautz EK, Dübel S.
    J Mol Recognit; 1999; 12(2):103-11. PubMed ID: 10398401
    [Abstract] [Full Text] [Related]

  • 2. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I, Lambrianides N, Latchman D, Chen P, Chukwuocha R, Isenberg D, Rahman A.
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [Abstract] [Full Text] [Related]

  • 3. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
    Rosok MJ, Eghtedarzadeh-Kondri M, Young K, Bajorath J, Glaser S, Yelton D.
    J Immunol; 1998 Mar 01; 160(5):2353-9. PubMed ID: 9498776
    [Abstract] [Full Text] [Related]

  • 4. Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis.
    Vajdos FF, Adams CW, Breece TN, Presta LG, de Vos AM, Sidhu SS.
    J Mol Biol; 2002 Jul 05; 320(2):415-28. PubMed ID: 12079396
    [Abstract] [Full Text] [Related]

  • 5. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS, Air GM.
    Biochemistry; 1998 Jul 28; 37(30):10660-70. PubMed ID: 9692956
    [Abstract] [Full Text] [Related]

  • 6. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.
    Xiang J, Sha Y, Jia Z, Prasad L, Delbaere LT.
    J Mol Biol; 1995 Oct 27; 253(3):385-90. PubMed ID: 7473721
    [Abstract] [Full Text] [Related]

  • 7. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
    Solem ST, Brandsdal BO, Smalås A, Jørgensen TØ.
    Mol Immunol; 2004 Apr 27; 40(18):1347-60. PubMed ID: 15072853
    [Abstract] [Full Text] [Related]

  • 8. Analysis of antigen binding and idiotypic expression by antibodies with polyglycine-replaced complementarity-determining regions.
    Sompuram SR, Den W, Sharon J.
    J Immunol; 1996 Feb 01; 156(3):1071-81. PubMed ID: 8557981
    [Abstract] [Full Text] [Related]

  • 9. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA, Stewart J, Benkovic SJ, Getzoff ED.
    J Mol Biol; 1994 Jan 21; 235(3):1098-116. PubMed ID: 8289310
    [Abstract] [Full Text] [Related]

  • 10. Characterization of an Ig VH idiotope that results in specific homophilic binding and increased avidity for antigen.
    Yan X, Evans SV, Kaminki MJ, Gillies SD, Reisfeld RA, Houghton AN, Chapman PB.
    J Immunol; 1996 Aug 15; 157(4):1582-8. PubMed ID: 8759742
    [Abstract] [Full Text] [Related]

  • 11. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW, Shan L, Broomell C, Ramsland PA, Fan Z, Anchin JM, Linthicum DS, Edmundson AB.
    J Mol Biol; 2000 Sep 29; 302(4):853-72. PubMed ID: 10993728
    [Abstract] [Full Text] [Related]

  • 12. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
    Honegger A, Malebranche AD, Röthlisberger D, Plückthun A.
    Protein Eng Des Sel; 2009 Mar 29; 22(3):121-34. PubMed ID: 19136675
    [Abstract] [Full Text] [Related]

  • 13. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
    Wang H, Chen D, Deng N, Xiang JJ, Jin YJ, Huang HL, Tang Y, Yang HY.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec 29; 23(12):1150-3. PubMed ID: 18062890
    [Abstract] [Full Text] [Related]

  • 14. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R, Bugli F, Mancini N, Rosa D, Di Campli C, Moroncini G, Manzin A, Abrignani S, Varaldo PE, Clementi M, Fadda G.
    Virology; 2001 Sep 15; 288(1):29-35. PubMed ID: 11543655
    [Abstract] [Full Text] [Related]

  • 15. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ, Brogle KC, Wang B, Kyle DJ, Soltis DA.
    Arch Biochem Biophys; 2005 Aug 15; 440(2):148-57. PubMed ID: 16051181
    [Abstract] [Full Text] [Related]

  • 16. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
    Pellequer JL, Chen Sw, Roberts VA, Tainer JA, Getzoff ED.
    J Mol Recognit; 1999 Aug 15; 12(4):267-75. PubMed ID: 10440998
    [Abstract] [Full Text] [Related]

  • 17. Identification of a nucleic acid-binding region within the largest subunit of Drosophila melanogaster RNA polymerase II.
    Kontermann RE, Kobor M, Bautz EK.
    Protein Sci; 1993 Feb 15; 2(2):223-30. PubMed ID: 8443600
    [Abstract] [Full Text] [Related]

  • 18. Probing the interaction between a high-affinity single-chain Fv and a pyrimidine (6-4) pyrimidone photodimer by site-directed mutagenesis.
    Kobayashi H, Morioka H, Tobisawa K, Torizawa T, Kato K, Shimada I, Nikaido O, Stewart JD, Ohtsuka E.
    Biochemistry; 1999 Jan 12; 38(2):532-9. PubMed ID: 9888792
    [Abstract] [Full Text] [Related]

  • 19. Tolerance of single, but not multiple, amino acid replacements in antibody VH CDR 2: a means of minimizing B cell wastage from somatic hypermutation?
    Brown M, Rittenburg MB, Chen C, Roberts VA.
    J Immunol; 1996 May 01; 156(9):3285-91. PubMed ID: 8617951
    [Abstract] [Full Text] [Related]

  • 20. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H, Nie Y, Huse WD, Watkins JD.
    J Mol Biol; 1999 Nov 19; 294(1):151-62. PubMed ID: 10556035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.